Glycopyrronium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1554 publications

Safety and Effectiveness of Indacaterol/Glycopyrronium/Mometasone Dry Powder Inhaler in Asthma: A Prospective Multicenter Phase IV Study.

Safety and Effectiveness of Indacaterol/Glycopyrronium/Mometasone Dry Powder Inhaler in Asthma: A Prospective Multicenter Phase IV Study.

Journal: The Journal of the Association of Physicians of India
Published: August 03, 2026

Toward Next-Generation Propellants: Assessing Lung Deposition of Beclometasone Dipropionate, Formoterol, and Glycopyrrolate Formulated with HFA-152a Using Functional Respiratory Imaging.

Toward Next-Generation Propellants: Assessing Lung Deposition of Beclometasone Dipropionate, Formoterol, and Glycopyrrolate Formulated with HFA-152a Using Functional Respiratory Imaging.

Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: July 16, 2026

Clinical pharmacist-led intervention improves anxiety, depression and inhaler technique in budesonide/glycopyrronium/formoterol-using patients: A single-center prospective randomized cohort study.

Clinical pharmacist-led intervention improves anxiety, depression and inhaler technique in budesonide/glycopyrronium/formoterol-using patients: A single-center prospective randomized cohort study.

Journal: Pakistan journal of pharmaceutical sciences
Published: July 11, 2026

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

Journal: COPD
Published: June 09, 2026

In uncontrolled asthma, adding glycopyrronium to budesonide-formoterol reduced annualized severe exacerbations.

In uncontrolled asthma, adding glycopyrronium to budesonide-formoterol reduced annualized severe exacerbations.

Journal: Annals of internal medicine
Published: June 01, 2026

Effect of neuromuscular blockade reversal strategy on gastrointestinal recovery following abdominal wall reconstruction: a randomized controlled trial.

Effect of neuromuscular blockade reversal strategy on gastrointestinal recovery following abdominal wall reconstruction: a randomized controlled trial.

Journal: Hernia : the journal of hernias and abdominal wall surgery
Published: May 20, 2026

Topical glycopyrronium bromide as a cause of pupillary changes

Topical glycopyrronium bromide as a cause of pupillary changes

Journal: Ugeskrift for laeger
Published: April 30, 2026

Utilization Patterns of Nebulized Glycopyrronium in Patients Hospitalized for Acute Exacerbations of Obstructive Airway Disease (AEOAD)-Indian Expert Perspectives.

Utilization Patterns of Nebulized Glycopyrronium in Patients Hospitalized for Acute Exacerbations of Obstructive Airway Disease (AEOAD)-Indian Expert Perspectives.

Journal: Advances in respiratory medicine
Published: April 24, 2026

Advances in pharmacological treatment and management of hyperhidrosis.

Advances in pharmacological treatment and management of hyperhidrosis.

Journal: Expert opinion on pharmacotherapy
Published: March 23, 2026

A 17-year-old boy with hemifacial flushing and anhidrosis.

A 17-year-old boy with hemifacial flushing and anhidrosis.

Journal: JAAD case reports
Published: March 20, 2026

Advances in the Management of Hyperhidrosis.

Advances in the Management of Hyperhidrosis.

Journal: Skin therapy letter
Published: March 16, 2026

Glycopyrronium Bromide versus Droperidol for Prophylaxis of Postoperative Nausea and Vomiting in Hysteroscopic Day Surgery: A Randomized, Double-Blind, Non-Inferiority Trial.

Glycopyrronium Bromide versus Droperidol for Prophylaxis of Postoperative Nausea and Vomiting in Hysteroscopic Day Surgery: A Randomized, Double-Blind, Non-Inferiority Trial.

Journal: Drug design, development and therapy
Published: March 11, 2026
Showing 1-12 of 1,554

Last Updated: 09/26/2026